SELLAS Life Sciences Group, Inc. (SLS) NASDAQ

1.56

-0.12(-7.14%)

Updated at May 09 04:00PM

Currency In USD

Valuation

Market Cap636.51M
Enterprise Value623.52M
P/E Ratio-3.74
PEG Ratio-0.17
Price/Sales Ratio0
Price/Book Ratio12.19
Enterprise/Revenue0
Enterprise/EBITDA-6.16

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-1.59
Return On Equity-3.25

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-30.88M
Net Income-30.88M
Diluted EPS-0.05

Balance Sheet

Total Cash13.89M
Total Cash/Share0.19
Total Debt1M
Total Debt/Equity0.11
Current Ratio1.72
Book Value Per Share0.13

Price History

52-Week Change14.71
52-Week High1.85
52-Week Low0.77
Moving Average 50 Days1.25
Moving Average 200 Days1.2

Statistics

Average Volume1.39M
Shares Outstanding94.55M
% Held by Institutions9.95

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:50
Last Split DateNovember 08, 2019